Leukemia, Lymphocytic, Chronic, B-Cell, drug therapy
- Name
- Leukemia, Lymphocytic, Chronic, B-Cell, drug therapy
- Accession Number
- DBCAT005037
- Description
Not Available
- Drugs
Drug Drug Description Ublituximab A low-fucose CD20-targeted monoclonal antibody used in the treatment of relapsing forms of multiple sclerosis. - Drugs & Drug Targets
Drug Target Type Ublituximab B-lymphocyte antigen CD20 target